granisetron and Neoplasms

granisetron has been researched along with Neoplasms in 126 studies

Research

Studies (126)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.79)	18.7374
1990's	45 (35.71)	18.2507
2000's	43 (34.13)	29.6817
2010's	30 (23.81)	24.3611
2020's	7 (5.56)	2.80

Authors

Authors	Studies
Akiyoshi, S; Hirose, L; Iwata, M; Kohara, H; Liao, J; Sawada, R; Tani, K; Yamanishi, Y	1
Hiraki, Y; Hori, M; Kawanaka, H; Matsuo, N; Miyashita, H; Miyoshi, T; Odawara, M	1
Huang, WH; Li, MJ	1
Araki, T; Nagamine, A; Obayashi, K; Ohshima, S; Takahashi, E; Takahashi, Y; Uchiyama, C; Yamamoto, K; Yashima, H	1
Adib-Majlesi, M; Hajigholami, A; Moghaddas, A; Riechelmann, R; Sabzghabaee, AM	1
Ebrahimi, M; Mehrzad, V; Moghaddas, A	1
Chua, AV; Hernandez, ARB; Real, IO	1
Carroll, E; Gamble, M; Glode, AE; Wright, GC	1
Aston, J; Barbour, S; Berger, MJ; Bergsbaken, J; Bierman, PJ; Brandt, D; Dolan, DE; Ellis, G; Ettinger, DS; Hughes, M; Kim, EJ; Kirkegaard, S; Kloth, DD; Lagman, R; Lim, D; Loprinzi, C; Ma, CX; Maurer, V; Michaud, LB; Nabell, LM; Noonan, K; Roeland, E; Rugo, HS; Schwartzberg, LS; Scullion, B; Shead, DA; Timoney, J; Todaro, B; Urba, SG	1
Nyktari, V; Papaioannou, A; Spartinou, A	1
Ayuhara, H; Hama, T; Hayashi, T; Hirai, K; Inoue, K; Itoh, K; Kawasaki, Y; Kogure, Y; Nakao, M; Nishio, M; Shibata, K; Suzuki, K; Takeda, K; Tsuji, D; Yokoi, M	1
Bai, D; Du, Y; Gao, Y; He, S; Jiang, Z; Lu, D; Wang, F; Wang, N; Wang, Z; Zhu, S	1
Boccia, R; Calcanes, G; Caruana, D; McBride, A; Mosier, M; Vacirca, J	1
Erickson, R; Mosier, MC; Nebughr, N; Nibley, W	1
Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Yamada, Y; Yokoyama, H; Yoshimoto, K	1
Abdul Kassim, MS; Keat, CH; Phua, G; Poh, WK; Sriraman, M	1
Fujiwara, K; Katakami, N; Kitao, A; Matsumoto, K; Minami, H; Morita, S; Negoro, S; Shibata, N; Tanioka, M; Yamaguchi, S	1
Goto, H; Myojo, T; Osawa, H	1
Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD	1
Ghani, NA; Keat, CH	1
Akashi, K; Arita, S; Ariyama, H; Baba, E; Komoda, M; Kumagai, H; Kusaba, H; Nagata, K; Nakano, M; Okumura, Y; Takaishi, S; Tamura, S; Uchida, M	1
Boccia, R; Cooper, W; Gabrail, N; Gralla, RJ; O'Boyle, E; Raftopoulos, H	1
Brygger, L; Herrstedt, J	1
Ahn, JS; Hong, YS; Kim, JE; Kim, KP; Kim, TW; Lee, J; Lee, JL; Park, SJ; Park, YS; Shin, DB; Sym, SJ	1
Boccia, R; Cooper, W; Gralla, RJ; O'Boyle, E; Raftopoulos, H	1
Arora, S; Chasen, M; Navari, R; Powers, D; Rapoport, B; Schnadig, I; Schwartzberg, L	1
Hou, F; Le, Q; Li, H; Li, W; Liu, S; Shi, Q; Zheng, L; Zong, S	1
Arata, K; Azuma, K; Fujiwara, K; Goto, K; Hashimoto, H; Hayashi, T; Kogure, Y; Matsui, R; Nagase, S; Nakao, M; Nogami, N; Ohyanagi, F; Seki, N; Shimada, T; Shimada, Y; Suzuki, K; Takeda, K; Takiguchi, T; Yamamoto, N; Yamanaka, T	1
Deeks, ED	1
Huang, Y; Liang, H; Liu, D; Liu, W; Si, X; Wang, L; Yu, Z; Zhang, H	1
Gao, LL; Huang, XE; Zhang, Q	1
Morrow, T	1
Behlendorf, T; Jordan, K; Kinitz, I; Schmoll, HJ; Voigt, W; Wolf, HH	1
Aogi, K; Inoue, K; Kitagawa, C; Mitsuhashi, S; Ogura, T; Saito, M; Sakai, H; Sekine, I; Yanagita, Y; Yoshizawa, H	1
Fujiwara, Y; Hashimoto, H; Hojo, T; Kaneko, M; Kato, Y; Katsumata, N; Kobayashi, Y; Satake, S; Takashima, A; Takeuchi, M; Yamamoto, H; Yonemura, M	1
Baum, C; Bello, CL; Dinolfo, M; Huang, X; Levine, S; Mulay, M; Patyna, S; Rosen, L; Toh, M; Van Vugt, A	1
Schulmeister, L	1
Chen, Q; Huang, C; Huang, J; Lin, T; Pan, L; Shen, H; Tian, W; Wang, J; Wang, Z; Zhang, L; Zhang, S; Zhou, J	1
Bi, F; Cao, D; Gou, HF; Hou, M; Jiang, M; Luo, de Y; Qiu, M; Shen, Y; Wang, J; Xu, F; Yang, Y; Yi, C; Zang, J; Zhou, XJ	1
Eguchi, K; Hoshi, E; Katsumata, N; Kawahara, M; Takagi, M; Takahashi, T	1
Boccia, RV; Clark, G; Gordan, LN; Grunberg, SM; Howell, JD	1
Daimon, T; Hashimoto, N; Ikematsu, Y; Kim, YI; Kimura, M; Maeda, M; Nakagaki, S; Taku, K; Tsubota, H; Tsuji, D	1
Abernethy, AP; Rangwala, F; Zafar, SY	1
Akalin, F; Berrak, SG; Cakir, FB; Canpolat, C; Yapar, O	1
Eguchi, K; Katakami, N; Katsumata, N; Kawahara, M; Saito, H; Yoshimori, K; Yoshizawa, H	1
Blower, PR	1
Aapro, MS; Bernhard, J; De Pree, C; Maibach, R; Sessa, C; Thuerlimann, B	1
Aapro, M; Bourke, JP	1
Aapro, M; Carides, AD; Evans, JK; Hargreaves, R; Hesketh, PJ; Horgan, KJ; Naylor, RJ; Tattersall, FD; Van Belle, S	1
Kelm-Kahl, I	1
Carmichael, J; Harris, AL	1
Russo, M	1
Aielli, F; Cannita, K; Marchetti, P; Narducci, F; Piccolo, D; Porzio, G	1
Aiello, R; Conti, G; Dimari, A; Mauceri, G; Tralongo, P	1
Seth, R; Tan, M; Xu, R	1
Goldsmith, B	1
Aapro, M	1
Fibich, C; Grothey, A; Jordan, K; Kegel, T; Schöbert, C	1
Barni, S; Cabiddu, M; Cazzaniga, M; Cremonesi, M; Di Cosimo, S; Ferretti, G; Ghilardi, M; Mandalà, M; Rocca, A	1
del Giglio, A; Moreno, J; Sahade, M	1
Feyer, P; Seegenschmiedt, MH; Steingraeber, M	1
Olver, IN	1
Acar, S; Baysal, K; Dagdemir, A; Elli, M; Pinarli, FG	1
Changkuingdee, N; Cheirsilpa, A; Chulaka, K; Sinthusake, T; Songsakkaesorn, A; Visawaprasit, S	1
Abali, H; Aynacioglu, AS; Babaoglu, MO; Bayar, B; Bozkurt, A; Celik, I; Kerb, R	1
Wilkes, G	1
Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A	1
Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K	1
Carmichael, J; Forfar, C; Harris, AL; Philip, PA	1
Golaszewski, T; Kölbl, H; Lahousen, M; Staab, HJ	1
Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T	1
Bremer, K; Cupissol, D; Dilly, SG; Goedhals, L; Noble, A	1
Fitts, D; Friedman, C; Gandara, D; Hall, S; Hesketh, P; Mailliard, J; Navari, R; Ritter, H	1
Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, R	1
Del Favero, A; Roila, F; Tonato, M	1
Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B	1
Soukop, M	2
Greenberg, M; Jacobson, SJ; Shore, RW; Spielberg, SP	1
Horibe, K; Katayama, I; Miyajima, Y; Numata, S	1
Dilly, S	1
Gandara, DR; Perez, EA	1
Palmer, R	1
Eisenberg, PD	1
Hanaoka, J; Hataya, I; Kodama, S; Maruhashi, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yanase, T; Yoshiya, N	1
Fujimoto, T; Hirota, T; Honjo, T; Katano, N; Kuroda, R; Saeki, K; Sakakibara, Y; Shimizu, H	2
Adenis, L; Allen, A; Bessell, E; Bressolle, F; Carmichael, J; Cupissol, D; Romain, D; Wargenau, M	1
Chevallier, B	2
Furue, H; Niitani, H; Ogawa, N; Ohta, K; Suminaga, M; Taguchi, T	1
Flander, MK; Jantunen, IT; Kataja, VV; Muhonen, TT; Teerenhovi, L	1
Jantunen, IT; Kataja, VV; Muhonen, TT; Parviainen, T	1
Cannata, G; Gebbia, N; Gebbia, V; Testa, A; Tirrito, ML; Valenza, R	1
Angelelli, B; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E	1
Contu, A; Depenni, R; Donati, D; Maestri, A; Meriggi, F; Olmeo, N; Piro, S; Sabbatini, R; Silingardi, V; Zaniboni, A	1
Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, RH; Perez, EA	1
Chang, CS; Chen, LT; Chen, TP; Huang, SM; Lin, SF; Liu, TC; Wei, TC	1
Handberg, J; Hansen, HH; Herrstedt, J; Larsen, L; Wessel, V	1
Koynov, KD; Tzekova, VI; Velikova, MT	1
Finley, RS; Stull, DM; Trovato, JA	1
Burghouts, J; de Wit, R; Fonteyn, M; Keizer, J; Nortier, J; Rodenburg, C; Slee, P; van den Berg, H; Verweij, J; Wils, J	1
Ben Dayan, D; Ben Zion, T; Cohen, AM; Kaufman, O; Mittelman, M; Zeidman, A	1
Ikeda, H; Koshiba, R	1
Asami, K; Hara, F; Hayashi, Y; Honna, T; Kaneko, M; Matsumura, T; Mimaya, J; Mugishima, H; Sawada, T; Sugimoto, T; Suita, S; Tsuchida, Y; Yamamoto, K; Yokoyama, J	1
Kaneko, M; Matsumura, T; Mugishima, H; Ohira, M; Onuma, N; Sakurai, M; Sawada, T; Sugimoto, T; Takeda, T	1
Castejon, AM; Cubeddu, LX; Hernandez, L; Paez, X	1
Barolo, JL; Blower, PR; Drapkin, R	1
Edelman, M; Gandara, DR; Hesketh, AM; Hesketh, PJ; Perez, EA; Roman, A	1
Alkiş, N; Kartum, A; Oge, A; Oge, O	1
Blackburn, LM; Burris, HA; Friedman, CJ; Gruben, D; Yocom, K	1
Abbott, B; Bruton, J; Champlin, R; Hecth, D; Ippoliti, C; Whaley, B	1
Barrajon, E; de las Peñas, R	1
Caparroz, C; Castro, PC; del Giglio, A; Soares, HP	1
Campos, D; Carides, AD; Carracedo, C; Erazo, A; Eriksson, LO; Gertz, BJ; Martinez-Cedillo, J; Pereira, JR; Poli, S; Reinhardt, RR; Vogel, C; Wittreich, J	1
Hirano, K; Honma, T; Mino, K; Nakabayashi, T; Saitoh, H; Sato, M; Takada, M; Takeda, T; Wada, I	1
Friedman, C; Lanciano, R; Michalski, J; Preston, AJ; Sherman, DM; Yocom, K	1
Allgar, V; Goss, I; Overend, M; Pedley, I; Riley, M; Watters, J; Whitehead, A	1
Keefe, DL	1
Bremer, K; Uhlenbusch, R	1
Goa, KL; Plosker, GL	1
Caubel, M; Cupissol, DR; Serrou, B	1
Falkson, G; van Zyl, AJ	1

Reviews

21 review(s) available for granisetron and Neoplasms

Article	Year
Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:12 Topics: Administration, Cutaneous; Administration, Oral; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting	2020
Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting. Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:12 Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Nausea; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Vomiting	2017
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects. Expert opinion on drug safety, 2014, Volume: 13, Issue:10 Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting	2014
Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison. Oncotarget, 2016, Apr-26, Volume: 7, Issue:17 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neoplasms; Network Meta-Analysis; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Spiro Compounds; Treatment Outcome; Vomiting	2016
Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting. Drugs, 2016, Volume: 76, Issue:18 Topics: Animals; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Granisetron; Humans; Injections; Nausea; Neoplasms; Vomiting	2016
Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:1 Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Gastrointestinal Diseases; Granisetron; Humans; Isoquinolines; Nausea; Neoplasms; Palliative Care; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting; Zingiber officinale	2012
Granisetron: relating pharmacology to clinical efficacy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:2 Topics: Antiemetics; Antineoplastic Agents; Drug Interactions; Granisetron; Humans; Neoplasms; Radiotherapy; Vomiting	2003
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:8 Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Granisetron; Humans; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ondansetron; Prodrugs; Serotonin; Serotonin Antagonists; Substance P; Vomiting	2003
First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron. Acta oncologica (Stockholm, Sweden), 2004, Volume: 43 Suppl 15 Topics: Age Factors; Aged; Antiemetics; Drug Resistance; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Radiotherapy; Receptors, Dopamine; Serotonin Antagonists; Vomiting	2004
Granisetron: an update on its clinical use in the management of nausea and vomiting. The oncologist, 2004, Volume: 9, Issue:6 Topics: Antiemetics; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Interactions; Granisetron; Heart; Humans; Liver Failure; Nausea; Neoplasms; Radiotherapy; Renal Insufficiency; Vomiting	2004
Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:9 Topics: Antiemetics; Antineoplastic Agents; Combined Modality Therapy; Granisetron; Humans; Nausea; Neoplasms; Radiotherapy; Serotonin Antagonists; Vomiting	2005
Update on anti-emetics for chemotherapy-induced emesis. Internal medicine journal, 2005, Volume: 35, Issue:8 Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Australia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Neoplasms; Ondansetron; Palonosetron; Patient Satisfaction; Prognosis; Quality of Life; Quinolizines; Quinuclidines; Treatment Outcome; Tropisetron; Vomiting	2005
Are there differences among the serotonin antagonists? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:5 Topics: Animals; Antiemetics; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Neoplasms; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting	1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3 Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting	1994
Granisetron (Kytril) clinical safety and tolerance. Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5 Topics: Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Female; Granisetron; Humans; Infusions, Intravenous; Male; Nausea; Neoplasms; Vomiting	1994
The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis. Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5 Topics: Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1994
Efficacy and safety of granisetron (Kytril) in two special patient populations: children and adults with impaired hepatic function. Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5 Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Dexamethasone; Granisetron; Humans; Infant; Liver Failure; Liver Neoplasms; Nausea; Neoplasms; Vomiting	1994
Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics. Seminars in oncology, 1994, Volume: 21, Issue:3 Suppl 5 Topics: Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Health Care Costs; Humans; Nausea; Neoplasms; Quality of Life; United States; Vomiting	1994
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials. Cancer, 2000, Dec-01, Volume: 89, Issue:11 Topics: Antiemetics; Antineoplastic Agents; Cross-Over Studies; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Randomized Controlled Trials as Topic; Serotonin Antagonists; Therapeutic Equivalency; Vomiting	2000
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern? The oncologist, 2002, Volume: 7, Issue:1 Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting	2002
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic. Drugs, 1991, Volume: 42, Issue:5 Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1991

Trials

72 trial(s) available for granisetron and Neoplasms

Article	Year
Palonosetron versus Granisetron in Combination with Aprepitant and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy: A Single-Institutional Retrospective Cohort Study. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:10 Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Female; Granisetron; Humans; Incidence; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Treatment Outcome; Vomiting	2021
[Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2017, Apr-12, Volume: 37, Issue:4 Topics: Acupuncture Therapy; Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Nausea; Neoplasms; Vomiting	2017
Method for individualized evaluation of antiemetic effect induced by 5-HT3 receptor antagonist. Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:5 Topics: Aged; Antiemetics; Creatinine; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Male; Middle Aged; Models, Biological; Nausea; Neoplasms; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists	2013
Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy? Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:1 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Logistic Models; Male; Metoclopramide; Middle Aged; Multivariate Analysis; Nausea; Neoplasms; Vomiting	2013
A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy. British journal of cancer, 2013, Aug-20, Volume: 109, Issue:4 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Camptothecin; Carboplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Endometrial Neoplasms; Female; Granisetron; Humans; Irinotecan; Logistic Models; Middle Aged; Morpholines; Neoplasms; Ovarian Neoplasms; Temperance; Treatment Outcome; Vomiting	2013
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:2 Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting	2014
Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, do Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:3 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Prospective Studies; Quinuclidines; Severity of Illness Index; Treatment Outcome; Vomiting	2015
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:6 Topics: Administration, Cutaneous; Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Female; Fluorouracil; Granisetron; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasms; Organoplatinum Compounds; Prospective Studies; Remission Induction; Republic of Korea; Safety; Vomiting	2015
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria. Future oncology (London, England), 2015, Volume: 11, Issue:18 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting	2015
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy. European journal of cancer (Oxford, England : 1990), 2016, Volume: 57 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Ondansetron; Randomized Controlled Trials as Topic; Retreatment; Serotonin 5-HT3 Receptor Antagonists; Spiro Compounds; Treatment Outcome; Vomiting; Young Adult	2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting	2016
The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:1 Topics: Adult; Antiemetics; Antineoplastic Agents; Asian People; China; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting	2009
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2009, Volume: 63, Issue:8 Topics: Administration, Oral; Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Female; Fluorouracil; Glucocorticoids; Granisetron; Humans; Infusions, Intravenous; Liposomes; Male; Methylprednisolone; Middle Aged; Neoplasms; Paclitaxel; Premedication; Treatment Outcome; Young Adult	2009
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. The Lancet. Oncology, 2009, Volume: 10, Issue:2 Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting	2009
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial. Japanese journal of clinical oncology, 2009, Volume: 39, Issue:7 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms; Prognosis; Single-Blind Method; Survival Rate; Treatment Outcome; Vomiting; Young Adult	2009
Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Nov-15, Volume: 15, Issue:22 Topics: Antineoplastic Agents; Arrhythmias, Cardiac; Aza Compounds; Dose-Response Relationship, Drug; Electrocardiography; Fluoroquinolones; Granisetron; Heart Ventricles; Humans; Indoles; Moxifloxacin; Neoplasms; Placebos; Protein-Tyrosine Kinases; Pyrroles; Quinolines; Risk; Sunitinib; Time Factors	2009
Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asian People; China; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Quinuclidines; Serotonin Antagonists; Survival Rate; Treatment Outcome; Vomiting; Young Adult	2011
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:5 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Megestrol; Metoclopramide; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Treatment Outcome; Vomiting	2011
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. Cancer science, 2010, Volume: 101, Issue:11 Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Hiccup; Humans; Japan; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Placebos; Treatment Outcome	2010
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:10 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting	2011
Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting; Young Adult	2012
Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:10 Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bradycardia; Child; Child, Preschool; Creatine Kinase; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Granisetron; Heart; Humans; Male; Neoplasms; Prospective Studies; Troponin T; Vomiting; Young Adult	2012
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4 Topics: Adult; Aged; Aprepitant; Cisplatin; Dexamethasone; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Vomiting	2013
A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Metoclopramide; Middle Aged; Neoplasms; Vomiting	2003
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy. Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:2 Topics: Adult; Antiemetics; Antineoplastic Agents; Area Under Curve; Cardiovascular Diseases; Electrocardiography; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting	2004
Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study. Current medical research and opinion, 2004, Volume: 20, Issue:6 Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; United States; Vomiting	2004
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting. Onkologie, 2005, Volume: 28, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting	2005
Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: a phase II study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Nausea; Neoplasms; Statistics, Nonparametric; Treatment Outcome; Vomiting	2005
Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer. Pediatric blood & cancer, 2006, Oct-15, Volume: 47, Issue:5 Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Nausea; Neoplasms; Ondansetron; Predictive Value of Tests; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome	2006
Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cisplatin; Dizziness; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting, Anticipatory	2005
Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists. Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:6 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Female; Gene Frequency; Genotype; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Polymorphism, Single Nucleotide; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Tropisetron; Vomiting	2005
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting	1995
A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting	1994
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Salvage Therapy; Vomiting	1995
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10 Topics: Adolescent; Adult; Aged; Cisplatin; Constipation; Diarrhea; Double-Blind Method; Female; Granisetron; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Serotonin; United States; Vomiting	1994
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The New England journal of medicine, 1995, Jan-05, Volume: 332, Issue:1 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting	1995
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3 Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting	1994
A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3 Topics: Awareness; Blood Pressure; Body Temperature; Cisplatin; Double-Blind Method; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Neoplasms; Patient Satisfaction; Pulse; Time Factors; Vomiting	1994
[Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Vomiting	1994
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Vomiting	1993
[Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Nausea; Neoplasms; Vomiting	1993
Evaluation of the bioequivalence of tablet and capsule formulations of granisetron in patients undergoing cytotoxic chemotherapy for malignant disease. Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:12 Topics: Adolescent; Adult; Antineoplastic Agents; Capsules; Chemistry, Pharmaceutical; Female; Granisetron; Humans; Male; Nausea; Neoplasms; Tablets; Therapeutic Equivalency; Vomiting	1993
The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group. British journal of cancer, 1993, Volume: 68, Issue:1 Topics: Blood Pressure; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pulse	1993
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9 Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Vomiting	1993
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Neoplasms; Ondansetron; Patient Satisfaction; Prospective Studies; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Vomiting	1993
Effects of granisetron with doxorubicin or epirubicin on ECG intervals. Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antiemetics; Doxorubicin; Drug Interactions; Electrocardiography; Epirubicin; Female; Granisetron; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Serotonin Antagonists	1996
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. Cancer, 1995, Nov-15, Volume: 76, Issue:10 Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prospective Studies; Vomiting	1995
An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1 Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting	1996
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy. Anti-cancer drugs, 1995, Volume: 6, Issue:5 Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Cross-Over Studies; Female; Granisetron; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting	1995
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Appetite; Cisplatin; Female; Follow-Up Studies; Granisetron; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Remission Induction; Safety; Time Factors; Vomiting	1997
Delayed emesis induced by moderately emetogenic chemotherapy: do we need to treat all patients? The Italian Group for Antiemetic Research. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:6 Topics: Acute Disease; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Granisetron; Humans; Male; Middle Aged; Neoplasms; Prognosis; Time Factors; Vomiting	1997
Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Neoplasms; Prednisolone; Statistics, Nonparametric; Treatment Outcome; Vomiting	1998
Granisetron in repeated cycles of chemotherapy with platinum. Neoplasma, 1998, Volume: 45, Issue:1 Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome	1998
Granisetron and ondansetron for chemotherapy-related nausea and vomiting. Haematologia, 1998, Volume: 29, Issue:1 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Vomiting	1998
[Comparison of antiemetic efficacy of granisetron as premedication versus combination therapy of granisetron]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12 Topics: Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Premedication; Vomiting	1998
Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, cross-over study. International journal of oncology, 1999, Volume: 14, Issue:4 Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Cross-Over Studies; Eating; Female; Granisetron; Humans; Infant; Male; Neoplasms; Time Factors; Treatment Outcome; Vomiting	1999
[Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9 Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Cisplatin; Drug Evaluation; Female; Granisetron; Humans; Infant; Leukemia; Male; Nausea; Neoplasms; Vomiting, Anticipatory	1999
Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Male; Microdialysis; Middle Aged; Neoplasms; Ondansetron; Serotonin; Serotonin Antagonists; Vomiting	1999
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Prochlorperazine; Treatment Outcome; Vomiting	2000
Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin. Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:1 Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Cost-Benefit Analysis; Female; Granisetron; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting, Anticipatory	2000
Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy. The oncologist, 2000, Volume: 5, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Sex Factors; Vomiting, Anticipatory	2000
Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation. Bone marrow transplantation, 2000, Volume: 25, Issue:12 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Dexamethasone; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome; Whole-Body Irradiation	2000
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:4 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Cross-Over Studies; Drug Costs; Female; Granisetron; Health Care Costs; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting	2000
Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Mar-15, Volume: 19, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antiemetics; Aprepitant; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Morpholines; Neoplasms; Vomiting	2001
Pharmacokinetics of granisetron in adults and children with malignant diseases. Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:4 Topics: Adolescent; Aged; Aging; Antiemetics; Antineoplastic Agents; Area Under Curve; Child; Female; Granisetron; Half-Life; Humans; Infant; Injections, Intravenous; Kidney; Liver Function Tests; Lung Neoplasms; Male; Neoplasms	2001
The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer investigation, 2001, Volume: 19, Issue:8 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antiemetics; Dose Fractionation, Radiation; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Radiotherapy; Tablets; Vomiting	2001
The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting. Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting	2001
[Comparison of the antiemetic effectiveness of granisetron and alizapride plus dexamethasone in cytostatic therapy]. Deutsche medizinische Wochenschrift (1946), 1991, Nov-29, Volume: 116, Issue:48 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Ifosfamide; Indazoles; Male; Middle Aged; Neoplasms; Pyrrolidines; Serotonin Antagonists; Single-Blind Method	1991
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic. Drugs, 1991, Volume: 42, Issue:5 Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1991
A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Time Factors; Vomiting	1990
The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Adult; Aged; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Sex Factors; Time Factors; Vomiting	1990
Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Headache; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Neoplasms; Serotonin Antagonists; Single-Blind Method; Vomiting	1990

Other Studies

35 other study(ies) available for granisetron and Neoplasms

Article	Year
Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation. Journal of medicinal chemistry, 2018, 11-08, Volume: 61, Issue:21 Topics: Antineoplastic Agents; Computational Biology; Drug Repositioning; Neoplasms	2018
Postoperative Serotonin Syndrome Following Administration of Preoperative Intrapulmonary Methylene Blue and Intraoperative Granisetron: A Case Report. The American journal of case reports, 2022, May-27, Volume: 23 Topics: Female; Granisetron; Humans; Methylene Blue; Middle Aged; Neoplasms; Serotonin; Serotonin Syndrome	2022
Comparison of the Antiemetic Effect of Aprepitant/granisetron and Palonosetron Combined with Dexamethasone in Gynecological Cancer Patients Treated with Paclitaxel and Carboplatin Combination Regimen. Die Pharmazie, 2022, 05-01, Volume: 77, Issue:5 Topics: Anorexia; Antiemetics; Aprepitant; Carboplatin; Dexamethasone; Female; Granisetron; Humans; Nausea; Neoplasms; Paclitaxel; Palonosetron; Retrospective Studies; Vomiting	2022
Potential drug-drug Interactions in hospitalized cancer patients: A report from the Middle-East. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cross-Sectional Studies; Dopamine Antagonists; Drug Interactions; Female; Granisetron; Hospitals, University; Humans; Inpatients; Iran; Male; Metoclopramide; Middle Aged; Middle East; Neoplasms; Retrospective Studies; Serotonin Antagonists; Young Adult	2021
Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran. Asian Pacific journal of cancer prevention : APJCP, 2020, Jun-01, Volume: 21, Issue:6 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Granisetron; Guideline Adherence; Humans; Induction Chemotherapy; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Vomiting	2020
Comparison of two different intravenous serotonin antagonists used for chemotherapy-induced nausea and vomiting prophylaxis in patients treated with moderately emetogenic risk regimens: A retrospective analysis from a large academic medical center. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:8 Topics: Academic Medical Centers; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult	2020
NCCN Guidelines Insights: Antiemesis, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN, 2017, Volume: 15, Issue:7 Topics: Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Granisetron; Humans; Neoplasms; Olanzapine; Serotonin Antagonists; Vomiting	2017
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:5 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Dexamethasone; Female; Genetic Predisposition to Disease; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Vomiting	2018
Hydration requirements with emetogenic chemotherapy: granisetron extended-release subcutaneous versus palonosetron. Future oncology (London, England), 2018, Volume: 14, Issue:14 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Injections, Subcutaneous; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Treatment Outcome; Vomiting	2018
Hydration requirements in patients receiving highly emetogenic chemotherapy. Future oncology (London, England), 2019, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Female; Fluid Therapy; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Palonosetron; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting; Young Adult	2019
[Comparison of antiemesis effects of granisetron, aprepitant and dexamethasone to palonosetron, aprepitant and dexamethasone in treatment of high-emetic risk chemotherapy-induced nausea and vomiting - a retrospective study for efficacy and safety in a sin Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:5 Topics: Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Dexamethasone; Drug Combinations; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Risk; Vomiting	2013
Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12 Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Granisetron; Humans; Malaysia; Metoclopramide; Nausea; Neoplasms; Prognosis; Retrospective Studies; Vomiting	2013
Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:1 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Japan; Male; Middle Aged; Morpholines; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Vomiting	2014
Transdermal patch tailors antinausea treatment. Managed care (Langhorne, Pa.), 2008, Volume: 17, Issue:12 Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Granisetron; Humans; Managed Care Programs; Medical Oncology; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Premedication; Serotonin 5-HT2 Receptor Antagonists	2008
Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy. European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:7 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Dexamethasone; Drug Administration Schedule; Female; Granisetron; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Safety; Treatment Outcome	2009
Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting. Clinical journal of oncology nursing, 2009, Volume: 13, Issue:6 Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	2009
Rapid intravenous administration of granisetron prior to chemotherapy is not arythmogenic: results of a pilot study. European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:7 Topics: Adult; Aged; Anti-Arrhythmia Agents; Antiemetics; Arrhythmias, Cardiac; Electrocardiography; Female; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects	2003
[Glucocorticoids: a two-edged sword in tumor therapy?]. Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33 Topics: Animals; Antiemetics; Antineoplastic Agents; Apoptosis; Drug Therapy, Combination; Female; Genetic Therapy; Glucocorticoids; Granisetron; Humans; Male; Mice; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Tumor Cells, Cultured; Vomiting	2003
[Re: Peter Blower's recent review of granisetron]. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:1 Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Neoplasms; Radiotherapy; Vomiting	2004
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:3 Topics: Aged; Female; Granisetron; Humans; Infusions, Intravenous; Neoplasms; Pruritus; Serotonin Antagonists	2004
Central nervous system side-effects of 5-HT3-receptor antagonists in elderly cancer patients treated with chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:6 Topics: Aged; Antineoplastic Agents; Central Nervous System Diseases; Clinical Trials as Topic; Granisetron; Humans; Neoplasms; Ondansetron; Serotonin Antagonists	2004
Low-dose granisetron for prophylaxis of acute chemotherapy-induced nausea and vomiting: a pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Pilot Projects; Serotonin Antagonists; Surveys and Questionnaires; Vomiting	2005
5HT3-receptor antagonists as antiemetics in cancer. Drug and therapeutics bulletin, 2005, Volume: 43, Issue:8 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting	2005
Antiemetic agents. Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:8 Suppl Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting	2007
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2007, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting	2007
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting	2008
An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease. Cancer chemotherapy and pharmacology, 1995, Volume: 37, Issue:1-2 Topics: Adult; Aged; Antiemetics; Electrocardiography; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Serotonin Antagonists; Vomiting	1995
[Granisetron, a antiemetic for treatment of cytostatic drug-induced vomiting: results of a practice-oriented study]. Wiener klinische Wochenschrift, 1995, Volume: 107, Issue:20 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Austria; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Longitudinal Studies; Male; Middle Aged; Neoplasms; Treatment Outcome; Vomiting	1995
The efficacy and safety of granisetron in pediatric cancer patients who had failed standard antiemetic therapy during anticancer chemotherapy. The American journal of pediatric hematology/oncology, 1994, Volume: 16, Issue:3 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Granisetron; Humans; Male; Neoplasms; Prospective Studies; Vomiting	1994
Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. The American journal of pediatric hematology/oncology, 1994, Volume: 16, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Granisetron; Humans; Infant; Male; Neoplasms; Prospective Studies; Vomiting	1994
Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy. The Kaohsiung journal of medical sciences, 1997, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Vomiting	1997
Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jun-15, Volume: 55, Issue:12 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vomiting	1998
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles. British journal of cancer, 1998, Volume: 77, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1998
Effect of granisetron on performance status during high-dose interferon therapy. Oncology, 1999, Volume: 57, Issue:4 Topics: Activities of Daily Living; Adult; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Interferon alpha-2; Interferon-alpha; Karnofsky Performance Status; Male; Middle Aged; Neoplasms; Quality of Life; Recombinant Proteins; Serotonin Antagonists; Treatment Outcome; Vomiting	1999
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:3 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Tolerance; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Pyrazoles; Serotonin Antagonists; Vomiting	1989